Ignite Creation Date:
2025-12-24 @ 5:17 PM
Ignite Modification Date:
2026-01-08 @ 10:19 PM
Study NCT ID:
NCT03098550
Status:
COMPLETED
Last Update Posted:
2021-07-23
First Post:
2017-03-28
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Test the Safety and Effectiveness of Nivolumab Combined With Daratumumab in Patients With Pancreatic, Non-Small Cell Lung or Triple Negative Breast Cancers, That Have Advanced or Have Spread
Sponsor:
Bristol-Myers Squibb
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-06-15
Start Date Type:
ACTUAL
Primary Completion Date:
2020-07-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-07-06
Completion Date Type:
ACTUAL
First Submit Date:
2017-03-28
First Submit QC Date:
None
Study First Post Date:
2017-03-31
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2021-07-02
Results First Submit QC Date:
None
Results First Post Date:
2021-07-23
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-07-02
Last Update Post Date:
2021-07-23
Last Update Post Date Type:
ACTUAL